粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

刘国栋; 周丽; 张文静; 王卓

doi:10.3969/j.issn.1006-0111.2018.02.019

粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

doi: 10.3969/j.issn.1006-0111.2018.02.019

1.
解放军477医院, 湖北襄阳 441003;第二军医大学附属长海医院, 上海 200433
2.
解放军477医院, 湖北襄阳 441003
3.
第二军医大学附属长海医院, 上海 200433

Effectiveness and safeness of granulocyte macrophage colony stimulating factor and whole lung lavage therapy in idiopathic pulmonary alveolar proteinosis

1.
No. 477 Hospital of PLA, Xiangyang 441003, China;Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China
2.
No. 477 Hospital of PLA, Xiangyang 441003, China
3.
Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

摘要: 目的观察粒细胞巨噬细胞刺激因子（GM-CSF）联合全肺灌洗治疗特发性肺泡蛋白沉积症（IPAP）的疗效和安全性。方法选取2015年8月至2017年3月在第二军医大学附属长海医院就诊的2例IPAP患者，经全肺灌洗后，分别予皮下注射和雾化吸入GM-CSF治疗，观察其疗效和安全性。结果 2例患者经GM-CSF联合全肺灌洗治疗，病情缓解。结论 GM-CSF联合全肺灌洗治疗对IPAP患者治疗有效、用药安全。
- 肺泡蛋白沉积症 /
- 全肺灌洗 /
- 粒细胞巨噬细胞刺激因子 /
- 治疗效果
Abstract: Objective To observe the effectiveness and safeness of granulocyte macrophage colony stimulating factor(GM-CSF) and whole lung lavage therapy for patients with idiopathic pulmonary alveolar proteinosis (IPAP). Methods Two IPAP patients who were hospitalized in Changhai Hospital from August 2015 to March 2017 were enrolled for the study. Both patients were treated with GM-CSF therapy after whole lung lavage. One patient received GM-CSF by subcutaneous injection and the other by inhalation. Results Both patients' conditions were improved after GM-CSF and whole lung lavage therapy. Conclusion Treatment with subcutaneous injection or inhalation of granulocyte macrophage colony stimulating factor and whole lung lavage is safe and effective for IPAP patients.
- pulmonary alveolar proteinosis /
- whole lung lavage /
- granulocyte macrophage colony stimulating factor /
- treatment outcome

[1]	Huaringa AJ, Francis WH. Pulmonary alveolar proteinosis:a case report and world literature review[J]. Respirol Case Rep, 2016, 4(6):e00201.
[2]	郭文亮, 曾运祥, 苏柱泉等. 粒细胞-巨噬细胞集落刺激因子雾化吸入治疗自身免疫性肺泡蛋白沉积症一例并文献复习[J]. 中华结核和呼吸杂志, 2015, 38(10):751-755.
[3]	Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis[J]. Science, 1994, 264(5159):713-716.
[4]	Stanley E, Lieschke G J, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology[J]. Proc Natl Acad Sci U S A, 1994, 91(12):5592-5596.
[5]	Nishinakamura R, Nakayama N, Hirabayashi Y, et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal[J]. Immunity, 1995, 2(3):211-222.
[6]	Griese M. Pulmonary alveolar proteinosis:a comprehensive clinical perspective[J]. Pediatrics,2017,140(2):e20170610.
[7]	卢惠伦, 罗益锋. 体外膜肺氧合下行全肺大容量灌洗治疗肺泡蛋白沉积症1例并文献复习[J]. 现代医院, 2010, 10(3):13-14.
[8]	Xu Z, Jing J, Wang H, et al. Pulmonary alveolar proteinosis in China:a systematic review of 241 cases[J]. Respirology, 2009, 14(5):761-766.
[9]	赵玉月, 徐作军. 肺泡蛋白沉积症的治疗进展[J]. 中华结核和呼吸杂志, 2014, 37(6):444-447.
[10]	Bonella F, Bauer PC, Griese M, et al. Pulmonary alveolar proteinosis:new insights from a single-center cohort of 70 patients[J]. Respir Med, 2011, 105(12):1908-1916.
[11]	Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis[J]. Am J Respir Crit Care Med, 2001, 163(2):524-531.
[12]	Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis[J]. Chest, 2006, 130(1):227-237.
[13]	Schoch OD, Schanz U, Koller M, et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF[J]. Thorax, 2002, 57(3):277-280.
[14]	Anderson PM, Markovic SN, Sloan JA, et al. Aerosol granulocyte macrophage-colony stimulating factor:a low toxicity, lung-specific biological therapy in patients with lung metastases[J]. Clin Cancer Res, 1999, 5(9):2316-2323.
[15]	Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis[J]. Am J Respir Crit Care Med, 2010, 181(12):1345-1354.

[1]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[2]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[3]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[4]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[5]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[6]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[7]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[8]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 457-460, 502. doi: 10.12206/j.issn.2097-2024.202405059
[9]	刘依秦, 王超群, 邱娇娜. 胆宁片预处理在糖尿病患者结肠镜检查前的应用效果分析 . 药学实践与服务, 2024, 42(9): 407-410. doi: 10.12206/j.issn.2097-2024.202407037
[10]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[11]	刘汝雄, 杨万镇, 涂杰, 盛春泉. 铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
[12]	张广雨, 杜晶, 刘梦珍, 朱丹妮, 闫慧, 刘冲. 新斯的明与山莨菪碱联合应用对肺型氧中毒的保护作用及其机制的研究 . 药学实践与服务, 2024, 42(10): 433-438, 444. doi: 10.12206/j.issn.2097-2024.202310049
[13]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[14]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027
[15]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050
[16]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[17]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[18]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[19]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[20]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054

点击查看大图

计量

文章访问数: 3474
HTML全文浏览量: 369
PDF下载量: 903
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

doi: 10.3969/j.issn.1006-0111.2018.02.019

Effectiveness and safeness of granulocyte macrophage colony stimulating factor and whole lung lavage therapy in idiopathic pulmonary alveolar proteinosis

计量

粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

doi: 10.3969/j.issn.1006-0111.2018.02.019

1. 解放军477医院, 湖北襄阳 441003;第二军医大学附属长海医院, 上海 200433

2. 解放军477医院, 湖北襄阳 441003

3. 第二军医大学附属长海医院, 上海 200433

English Abstract

Effectiveness and safeness of granulocyte macrophage colony stimulating factor and whole lung lavage therapy in idiopathic pulmonary alveolar proteinosis

1. No. 477 Hospital of PLA, Xiangyang 441003, China;Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

2. No. 477 Hospital of PLA, Xiangyang 441003, China

3. Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

全文HTML

目录

留言板

粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

doi: 10.3969/j.issn.1006-0111.2018.02.019

Effectiveness and safeness of granulocyte macrophage colony stimulating factor and whole lung lavage therapy in idiopathic pulmonary alveolar proteinosis

计量

出版历程

粒细胞巨噬细胞刺激因子联合全肺灌洗对特发性肺泡蛋白沉积症的疗效和安全性

doi: 10.3969/j.issn.1006-0111.2018.02.019

1. 解放军477医院, 湖北 襄阳 441003;第二军医大学附属长海医院, 上海 200433 2. 解放军477医院, 湖北 襄阳 441003 3. 第二军医大学附属长海医院, 上海 200433

English Abstract

Effectiveness and safeness of granulocyte macrophage colony stimulating factor and whole lung lavage therapy in idiopathic pulmonary alveolar proteinosis

1. No. 477 Hospital of PLA, Xiangyang 441003, China;Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China 2. No. 477 Hospital of PLA, Xiangyang 441003, China 3. Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

全文HTML

目录

1. 解放军477医院, 湖北襄阳 441003;第二军医大学附属长海医院, 上海 200433

2. 解放军477医院, 湖北襄阳 441003

3. 第二军医大学附属长海医院, 上海 200433

1. No. 477 Hospital of PLA, Xiangyang 441003, China;Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China

2. No. 477 Hospital of PLA, Xiangyang 441003, China

3. Changhai Hospital Affiliated to Second Military Medical University, Shanghai 200433, China